Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001410578-22-002585
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Net Income | $207.00K | -$11.30K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
